Artemis Hospitals
| India | Turchia | Austria | |
| Trachelectomia uterina | da $4,500 | da $5,500 | da $14,500 |
| Terapia protonica per il cancro alla prostata | da $35,000 | da $30,000 | da $80,000 |
| Terapia protonica per il cancro al seno | da $26,000 | da $30,000 | da $55,000 |
| Terapia con protoni | da $25,000 | da $70,000 | da $80,000 |
| Radioterapia per il cancro colorettale | da $3,200 | da $7,000 | da $12,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Adenocarcinoma. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Adenocarcinoma e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Adenocarcinoma.
Il medico si è laureato in Medicina presso l'Università di Mysore nel 1996, seguito da un Dottorato in Medicina in radioterapia presso l'Università Hindu di Banaras nel 2002. Per migliorare ulteriormente la sua esperienza, il medico ha conseguito un Diploma del Consiglio Nazionale in radioterapia nel 2004.<\/p>
Il medico è membro di diverse organizzazioni prestigiose, tra cui l'Associazione di Oncologia Radioterapica dell'India, la Società di Neuro-Oncologia, il Gruppo di Oncologia di Bangalore e l'Associazione Indiana di Oncologia Ipertermica, riflettendo un forte impegno per l'avanzamento del campo dell'oncologia.<\/p>
Il medico è uno specialista esperto in medicina nucleare presso l'HCG Manavata Cancer Centre con 12 anni nel campo. Il medico si specializza in vari esami nucleari, esami PET-CT e servizi di cardiologia nucleare, dimostrando competenza nelle terapie con radioiodio e Lu-177 RN. Nel corso della sua carriera, il medico ha gestito oltre 30.000 esami PET e trattato oltre 1.000 pazienti con cancro alla tiroide. Inoltre, il medico ha contribuito al campo attraverso articoli pubblicati in varie riviste mediche.<\/p>
La dottoressa è un'oncologa altamente qualificata specializzata nel trattamento di vari tipi di cancro, inclusi tumori solidi, tumori pediatrici e malignità ematologiche. È esperta in trattamenti sia conservativi che chirurgici, come la procedura di Whipple.<\/p>
Ha completato il suo MBBS al Lady Hardinge Medical College e il MD in medicina interna al Maulana Azad Medical College. Ha proseguito con il DM in Oncologia Medica al Tata Memorial Hospital, dove ha anche lavorato come consulente.<\/p>
È affiliata a società oncologiche internazionali e nazionali e ha esperienza in tumori polmonari, mammari, ginecologici e genitourinari, con un particolare interesse per l'immunoterapia e la terapia metronomica.<\/p>
Indian oncologists treating adenocarcinoma frequently hold international accreditations from respected global organizations. Many specialists earn certifications from the European Society for Medical Oncology (ESMO) or the American Society of Clinical Oncology (ASCO). Leading facilities maintain Joint Commission International (JCI) standards for safety.
Bookimed Expert Insight: Quality signals in India often follow a hub-and-spoke pattern. Major medical hubs like Gurgaon and Chennai house hospitals like Fortis and Global Hospital. These facilities report massive volumes, sometimes serving over 80,000 patients annually. Our data shows that high-volume surgeons, such as those at HCG Manavata with over 50,000 procedures, are those most likely to hold multiple international fellowships.
Patient Consensus: Patients note it is vital to travel to major cities for accredited care. They emphasize that video consultations help verify a doctor's global credentials before traveling.
India enforces safety for chemotherapy and radiation through statutory regulations from the Atomic Energy Regulatory Board and the National Cancer Grid. Facilities like Global Hospital Chennai and Manipal Hospital maintain JCI and NABH accreditations. These standards mandate precise tumor targeting and strict waste management protocols.
Bookimed Expert Insight: Quality indicators for safety are closely tied to specialist experience and clinical volume rather than just equipment. At HCG Manavata Cancer Centre, specialists like Dr. Raj Nagarkar have performed over 50,000 surgeries. This massive clinical volume allows institutions to refine safety checklists that common regulations might overlook.
Patient Consensus: Patients note that safety standards can vary significantly between facility tiers. They emphasize checking for current NABH or JCI accreditations before starting any long-term oncology treatment.
Indian oncology centers manage adenocarcinoma side effects using protocols from the National Cancer Grid and international standards. Support involves preventive nausea control with serotonin antagonists and specialized radiation skin care. Facilities like Artemis Hospitals and Medanta follow strict monitoring for toxicity and blood counts.
Bookimed Expert Insight: High-volume centers like HCG Manavata Cancer Centre, which serves 75,000 patients annually, integrate surgical and medical expertise to preemptively manage toxicity. Specialists like Dr. Raj Nagarkar have performed over 50,000 surgeries, emphasizing that experienced clinical teams often catch side effects earlier than smaller facilities. This proactive monitoring is key in large, JCI-accredited Indian hospitals.
Patient Consensus: Patients emphasize starting mouth and skin care regimens on day 1 to prevent severe reactions. Many suggest using natural alternatives like ginger tea for nausea and curd rice for managing digestive issues during radiation.
Smaller Indian cities like Nashik, Mohali, and Nadiad offer the shortest wait times for adenocarcinoma surgery. Private facilities in these hubs often schedule robotic or laparoscopic procedures in under 7 days. Major metros like Gurgaon and Bangalore maintain high-capacity systems with 7 to 20-day access.
Bookimed Expert Insight: While major metros have more robots, tier-2 cities like Nashik provide faster surgical slots due to lower international patient density. Dr. Raj Nagarkar in Nashik has performed over 50,000 surgeries. This high individual volume in smaller hubs often ensures both speed and significant surgical expertise.
Patient Consensus: Patients find that booking multiple consultations in cities like Mumbai or Delhi can secure a robotic slot within 10 days. Those choosing underrated hubs like Hyderabad report getting surgery dates in as little as 5 days post-biopsy.
A full adenocarcinoma treatment cycle in India typically requires 4 to 12 weeks. Stays vary by modality: surgery alone takes 2 to 6 weeks, while radiation requires 3 to 6 weeks. Combined protocols involving chemotherapy and surgery often extend stays to 3 months for safety.
Bookimed Expert Insight: High-volume centers like HCG Manavata or Global Hospital serve up to 80,000 patients yearly. This massive volume allows them to offer fast-track diagnostic bundles. Patients can often complete CT scans and oncology consultations within 48 hours. Using centers with 40+ staff oncologists typically shortens the pre-treatment phase by at least 1 week.
Patient Consensus: Patients note that lung or breast cancer cycles often hit the 10-week mark. It is important to pack for 2 months and book flexible flights to account for recovery buffers.
Continuing targeted therapy in India is generally feasible. Standard treatments like immunotherapy or tyrosine kinase inhibitors are available at major oncology centers. Global clinical trials however require specific approval from the study sponsor. The Indian facility must already be a registered site for that trial.
Bookimed Expert Insight: Private oncology centers in India offer a significant advantage for continuing complex care. Specialized facilities like HCG Manavata Cancer Centre participate in over 200 clinical trials. Dr. Raj Nagarkar there has extensive experience managing phase 1-3 studies. Choosing a center with high trial volume ensures the infrastructure for protocol continuity exists.
Patient Consensus: Patients note that switching trials often requires re-enrollment rather than a seamless transfer. Accessing targeted drugs is easier if you budget for potential 4–6 week import delays at customs.